Post by
subaru1i on Mar 30, 2024 10:28am
If anyone keeping score, it's 4 to 1. Pentagon, White House
, NIH, FDA vs DEA who we are waiting for. I hope everyone loaded up as much as possible because the DEA is not 'if' but merely what day now the news hits.
We are in the money spot with LABS because the Pentagon, NIH, and FDA only have 1 approved source in North America to acquire cannabinoid based molecules and so too goes for all the pharmaceutical companies.
It's worth at least +$40 per share, I'm just curious what management at LABS will cut the deal at because they need an 'accretive' partner to ramp up scale.